Binodenoson is a pharmacologic stress agent specific to the only adenosine receptor necessary for increased cardiac blood flow, the A2A receptor. This specificity allows Binodenoson to deliver - in a... This specificity allows Binodenoson to deliver - in a single injection - a more effective dose of medication with fewer side effects than current treatments, which typically require a 15-20 minute infusion.
- Mechanism
- Curator reviewed
Binodenoson is a highly selective adenosine A2A receptor agonist. The adenosine A2A receptor is necessary for increased cardiac blood flow, and specificity to this particular receptor allows binodenoson to deliver, in a single injection, a more effective dose of medication with fewer side effects than current treatments, which typically require a 15-20 minute infusion. Cardiac stress tests allow physicians to identify the presence of cardiovascular disease by examining the flow of blood through the heart.
- Primary indication
- For cardiac pharmacologic stress SPECT imaging, which is used to diagnose coronary artery disease.Curator reviewed
- Formula / weight
- C17H25N7O4 · 391.4249 g/mol (avg)
- Code names
- MRE-0470 · SHA-174 · WRC-0470
Resolves to
XJFMHMFFBSOEPR-DNZQAUTHSA-NSMILESOC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N)N=C(N\N=C\C3CCCCC3)N=C12What you can answer from here — as of August 26, 2024
Which drugs share a target with Binodenoson, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account